# DESCRIPTION

## FIELD OF THE INVENTION

- define field

## BACKGROUND OF THE INVENTION

- motivate HIV vaccine

## SUMMARY OF THE INVENTION

- define composition
- outline method

## DETAILED DESCRIPTION

- describe DNA vaccine encoding HIV antigenic constructs

### 1. DEFINITIONS

- define terminology
- explain numeric ranges
- define consensus sequence
- define treatment and substantially identical

### 2. COMPOSITION FOR PRIMING AND BOOSTING HIV IMMUNOLOGICAL RESPONSE

- introduce composition for priming and boosting HIV immunological response
- describe first vaccine composition
- describe administration of first vaccine
- describe second vaccine composition
- describe administration of second vaccine
- describe antigen composition
- describe nucleic acid sequence encoding antigen
- describe genetic modifications of nucleic acid sequence
- describe HIV antigen examples
- describe DNA composition
- describe vector composition
- describe expression vectors
- describe circular and linear vectors
- describe promoter, intron, stop codon, and polyadenylation signal
- describe other components of vaccine - adjuvants, excipients
- describe transfection facilitating agents
- describe adjuvants
- describe other genes as adjuvants
- describe formulation of vaccine

### 3. METHOD OF VACCINATION

- describe method of vaccinating patient
- administer composition to subject
- induce immune system against specific antigens
- deliver antigen to subject
- elicit antigen-specific antibody responses
- administer first vaccine
- administer second vaccine
- define dose of vaccine
- administer vaccine at specific time points
- administer multiple doses of vaccine
- formulate composition for administration
- administer prophylactically or therapeutically
- define therapeutically effective dose
- administer via various routes
- deliver via particles or beads
- administer via electroporation
- describe minimally invasive electroporation device
- inject vaccine into tissue without needle
- describe various types of tissues that can be treated
- describe various devices and systems for electroporation

### 4. EXAMPLES

- introduce animal models
- describe materials and methods
- construct and express HIV-1 envelope consensus sequences
- immunize mice and guinea pigs
- analyze humoral immune response using ELISA
- analyze cellular immune response using ELISpot and flow cytometry
- perform T-cell ELISpot assay
- perform B-cell ELISpot assay
- analyze intracellular cytokine staining
- perform antibody binding assay using ELISA
- produce HIV-1 single round pseudovirus
- perform HIV-1 neutralization assay
- analyze statistical significance
- describe designs of HIV-1 envelope consensus DNA vaccines
- describe vaccine immunogenicity assessment
- present ELISpot assay results
- analyze T-cell responses
- discuss polyfunctional T cell responses
- describe B-cell ELISpot results
- analyze humoral response
- present antibody levels in guinea pigs
- describe Western blot analysis
- analyze neutralizing antibody response
- discuss limitations of DNA vaccination
- describe improvements to DNA vaccine platform
- discuss T-cell response results
- analyze humoral response results
- discuss breadth of humoral response
- summarize conclusions

## 5. CLAUSES

- define composition of vaccines
- specify nucleic acids in first vaccine
- specify antigenic peptides in second vaccine
- describe method of immunizing against HIV-1
- specify administration timing of first vaccine
- specify administration timing of second vaccine

